Scientific Reports · 2018 · 36 citations · 20 references
MedicineMedicinal ChemistryPharmacologyApoptosisCancer PharmacologyMolecular OncologyApoptosis PharmacologyCytotoxic ChemotherapyMitotic InhibitorsOncology PharmacologyAnticancer ActivityAnticancer Mechanism Of ActionAntiproliferative AgentsAntiproliferative Drug ActionApoptotic Cell Death RegulationCancer Cell Proliferation InhibitionIsoquinoline AlkaloidsIsoquinoline Chemistry
Abstract Scoulerine is an isoquinoline alkaloid, which indicated promising suppression of cancer cells growth. However, the mode of action (MOA) remained unclear. Cytotoxic and antiproliferative properties were determined in this study. Scoulerine reduces the mitochondrial dehydrogenases activity of the evaluated leukemic cells with IC 50 values ranging from 2.7 to 6.5 µM. The xCELLigence system revealed that scoulerine exerted potent antiproliferative activity in lung, ovarian and breast carcinoma cell lines. Jurkat and MOLT-4 leukemic cells treated with scoulerine were decreased in proliferation and viability. Scoulerine acted to inhibit proliferation through inducing G2 or M-phase cell cycle arrest, which correlates well with the observed breakdown of the microtubule network, increased Chk1 Ser345, Chk2 Thr68 and mitotic H3 Ser10 phosphorylation. Scoulerine was able to activate apoptosis, as determined by p53 upregulation, increase caspase activity, Annexin V and TUNEL labeling. Results highlight the potent antiproliferative and proapoptotic function of scoulerine in cancer cells caused by its ability to interfere with the microtubule elements of the cytoskeleton, checkpoint kinase signaling and p53 proteins. This is the first study of the mechanism of scoulerine at cellular and molecular level. Scoulerine is a potent antimitotic compound and that it merits further investigation as an anticancer drug.
20
Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis)
Zbigniew Darżynkiewicz, Gloria Juan, Xun Li et al. · Cytometry · 1997 · 1.1K citations
Natural Product Communications
Natural Product Communications · 2018 · 656 citations · Full text
Cell Cycle–Targeted Cancer Therapies
Charles J. Sherr, Jiří Bártek · Annual Review of Cancer Biology · 2016 · 114 citations · Full text
Medicine, Cancer Biology, Oncology +17